| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 2014 | Oct 27, 2014 | Protara Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +691,713 | 122.78% | ✗ | $6.9M |
| Aug 5, 2014 | Aug 5, 2014 | Adverum Biotechnologies, Inc. | 10% Owner | Buy | 100.0 | +1,334,467 | 154.59% | ✗ | $31.9M |